127.82
-0.34%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Mesa Laboratories
From its filings with the US Securities and Exchange Commission
Mesa Laboratories is based in Lakewood, Colorado and is incorporated in Colorado. Its shares trade on Nasdaq under the ticker MLAB. The SEC classifies its business as industrial instruments for measurement, display, and control. In the fiscal year to 31 March 2026, it reported revenue of $249.1m and net income of $6.7m. At that date it held total assets of $427.7m and shareholders' equity of $186.2m.
In this annual report, Mesa Laboratories, Inc., a Colorado corporation, together with its subsidiaries is collectively referred to as “we,” “us,” “our,” the “Company,” or “Mesa.” Mesa was organized in 1982 as a Colorado corporation.
We are a global leader in the design and manufacture of life sciences tools and critical quality control solutions for regulated applications in the pharmaceutical, healthcare and medical device industries. We offer products and services to help our customers ensure product integrity, increase patient and worker safety, and improve the quality of life throughout the world. We have manufacturing operations in the United States and Europe, and our products are marketed by our sales personnel in North America, Europe and the Asia Pacific region ("APAC"), and by independent distributors throughout the world.
We are headquartered in Lakewood, Colorado and our common stock is listed for trading on the Nasdaq Global Market (“Nasdaq”) under the symbol MLAB.
We strive to create stakeholder value and further our purpose of Protecting the Vulnerable® by growing our business both organically and through acquisitions, by improving our operating efficiency, and by continuing to hire, develop and retain top talent. As a business, we commit to our purpose of Protecting the Vulnerable® every day by taking a customer-focused approach to developing, building and delivering our products and services. By delivering the highest quality products and services possible, we are committed to protecting the communities we serve.
Quoted from its 10-K, filed 3 Jun 2026. Read the filing on SEC.gov ↗
Company facts
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Listed since
- 29 Feb 1984
- Employees
- 717
- Website
- mesalabs.com ↗
- Head office
- 12100 W 6TH AVE, LAKEWOOD, CO, 80228
- Incorporated in
- CO
- Classification
- Industrial Instruments For Measurement, Display, and Control
- Filer status
- Accelerated filer
Leadership
Pay as last reported
- Dr. John SullivanIndependent Chairman of the Board, since 2004$285,105
- Mr. Gary OwensPresident, Chief Executive Officer, Director, since 2017$6.6m
- Mr. John SakysChief Financial Officer, Vice President$2.4m
- Mr. Brian ArchboldSenior Vice President - Continuous Improvement$2.1m
- Mr. Shiraz LadiwalaLead Independent Director$250,018
- Ms. Jennifer AlltoftIndependent Director$250,105
- Mr. Mark CaponeIndependent Director$240,105
- Ms. Shannon HallIndependent Director$250,105
- Mr. R. Tony TripenyIndependent Director$250,105
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 46
- Environment
- 61
- Social
- 56
- Governance
- 22
- Carbon reduction policy
- No
- Human rights policy
- Yes
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Mesa Laboratories Inc has a strong reputation in the market and an established presence in the industry. The company's advanced technology and innovative products give them a competitive advantage. Additionally, Mesa Laboratories Inc has a highly skilled and dedicated workforce, ensuring high-quality output and customer satisfaction.
Weaknesses
- Mesa Laboratories Inc may face challenges due to their limited global reach and lack of diversification in their product portfolio. This puts them at risk of being heavily impacted by changes in the market. Furthermore, the company's dependence on a few key suppliers could lead to potential supply chain disruptions.
Opportunities
- Mesa Laboratories Inc has an opportunity to expand its market share by targeting new geographic regions and exploring untapped customer segments. The demand for their specialized products is expected to increase as industries such as pharmaceuticals and medical devices continue to grow. Moreover, strategic partnerships and acquisitions can provide avenues for diversification and further business growth.
Threats
- Mesa Laboratories Inc faces the threat of intense competition from both established players and new entrants in the market. This could potentially impact their market share and profitability. Economic uncertainties and government regulations are also potential threats that could hinder the company's growth. Additionally, rapid advancements in technology pose the risk of their products becoming obsolete if they fail to keep up with the pace of innovation.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.